Biography
Dr Christopher Stanley is Leader of the Microvascular Research Unit at HRI and University of Sydney Research Affiliate.
Born in the United Kingdom, Dr Stanley completed his undergraduate Bachelor of Science degree in Pharmacology and Physiology at Leeds Metropolitan University with a first class honours and was awarded ‘Best Dissertation and Best Lab Project’ for his work in cannabinoid pharmacology. This was followed by doctoral studies in the same subject at the University of Nottingham, obtaining his PhD in 2013. Following this, he focused his interest on the project ‘Human microvascular structure and function’ at the University of Oxford with the laboratory of Professors Kim Dora and Chris Garland.
After moving to Australia in 2014, Dr Stanley joined Victor Chang Cardiac Research Institute and worked in the laboratory of Prof Roland Stocker on the project ‘Regulation of vascular tone through ID01 mediated vasorelaxation’. In his appointment, Dr Stanley was awarded a Society for Free Radical Research Young Investigator Award, a Sydney Cardiovascular Symposium Rising Star Award and the UNSW St Vincent’s Clinical School Publication of the Year Award.
In August 2020, Chris joined HRI to start and lead the Microvascular Research Unit.
Current appointments
Group Lead – Heart Research Institute
Research Affiliate – The University of Sydney
Prizes and awards
2020 UNSW St Vincent’s Clinical School Publication of the Year Award
2019 Sydney Cardiovascular Symposium Rising Star Award
2017 Victor Chang Cardiac Research Institute: Paul Korner Seminar Series, Faculty Award
2015 Society for Free Radical Research Young Investigator Award
2011 British Heart Foundation Travel Award
2011 British Pharmacological Society Competitive Travel Award
2010 British Pharmacological Society Competitive Travel Award
2009 Best Lab-based project: Leeds Metropolitan University
2009 Best Dissertation: Leeds Metropolitan University
Selected publications
Stanley CP et al. Singlet Molecular Oxygen Regulates Vascular Tone and Blood Pressure in Inflammation. Nature 2019; 566 p548.
Cheng D et al. Inhibition of myeloperoxidase attenuates endothelial dysfunction in mouse models of vascular inflammation and atherosclerosis. Arterioscl Thromb Vasc Biol 2019: 39: p1448.
Herring N et al. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction. Eur Heart J 2019; 40 p1920.
Zardoya-Laguardia P et al. Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia. Sci Rep 2018; 8 p5488.